Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Newborn screening is cost-effective in detecting rare but treatable genetic disease

03.11.2003


Screening newborns for a rare but treatable genetic disease benefits families and society, according to a team of pediatricians and health care economists who analyzed patient records and data from mass screening programs in several states. The study appears in the November issue of Pediatrics.



The researchers, from The Children’s Hospital of Philadelphia and The University of Pennsylvania School of Medicine, analyzed the cost-effectiveness of screening for medium-chain acyl-CoA-dehydrogenase deficiency, or MCADD. An inherited metabolic disease that impairs energy production from stores of body fat, MCADD may go undetected until it causes childhood death or brain damage.

"Our research showed that screening newborns for MCADD is cost-effective compared to not screening," said Charles P. Venditti, M.D., Ph.D., the study’s corresponding author. "Furthermore, as automated screening technology continues to enable expanded newborn screening for many genetic diseases, we may find similar benefits for other diseases." (A specialist in pediatric biochemical genetics at the University of Pennsylvania and The Children’s Hospital of Philadelphia during the period of the study, Dr. Venditti is now at the National Human Genome Research Institute of the National Institutes of Health.)


Drawing on records of 32 patients with MCADD treated at Children’s Hospital over a 30-year period, the researchers compared results for two hypothetical groups of patients, one that did not undergo newborn screening, another group that did receive the screening. Using decision-modeling methods, the researchers computed the costs of hospitalizations and lifetime medical services for chronic disease. "We found the cost of newborn screening for MCADD to be well below the accepted costs for other health care interventions, such as acute newborn intensive care or newborn hearing screening," said Dr. Venditti.

The current study considered the use of a recent technology called tandem mass spectrometry (TMS), which employs automated technology to detect particular biochemicals in a sample of newborn blood. An abnormally high value for certain fatty acids, amino acids or other chemicals may signal a genetic defect in how the body processes food. TMS can screen for more than 30 metabolic diseases. Many of these diseases are rare, but collectively they affect one in 4,000 newborns, approximately the same percentage affected by Down syndrome.

Routine newborn screening has been carried out in all 50 states since the 1970s for genetic diseases such as phenylketonuria (PKU) and congenital hypothyroidism, with a handful of other diseases added over the years on a state-by-state basis. The recent development of the TMS technique has greatly expanded the number of diseases that can be detected, but less than half of U.S. newborns receive TMS testing. TMS uses the same sample of blood required for the conventional screening tests.

Based on TMS statistics, the authors estimate MCADD to occur in 1 in 15,000 newborns, making it equally as common as PKU. Both diseases are devastating if untreated, but when managed, allow patients a normal quality of life.

"MCADD is a particularly sneaky disorder," said Charles A. Stanley, M.D., senior author of the study and chief of Endocrinology at The Children’s Hospital of Philadelphia. "A child with undetected MCADD can be perfectly normal, then get a viral illness and stop eating. After 12 hours of fasting, a child can become extremely ill and go into a life-threatening crisis. The MCADD defect interferes with metabolizing fat that the child needs for producing energy." The metabolic crisis can inflict heart failure, brain damage or even death. Some unexpected infant deaths, first attributed to sudden infant death syndrome, were later found to be the result of previously undiagnosed MCADD.

Dr. Stanley led the Children’s Hospital research team that discovered MCADD in 1983, simultaneously with independent reports from the University of Iowa and researchers in Denmark. It was the first fatty acid oxidation defect to be identified. Over the years, he has followed some two dozen patients with MCADD, some of whom had severe outcomes. He added, "I’m delighted to see a screening program applied to this very treatable disorder."

"Unlike some other metabolic diseases," say the study’s authors, "the complications of MCADD are preventable." Parents and caregivers who know a child has MCADD must be vigilant that the child does not miss feedings. If a child cannot eat for some reason, parents bring the child to a hospital to receive intravenous nourishment and prevent disease complications.

When the researchers projected their cost model over a 70-year period, they predicted that the savings obtained by avoiding the medical costs of undiagnosed disease would offset nearly all the additional costs of screening for MCADD. "It is plausible that newborn screening might even provide net savings to society, compared to the costs of not screening," said Dr. Venditti. "For instance, some studies suggest that people with asymptomatic MCADD, who have less severe forms of the disease than we find in children, may have higher risks of death and illness than people without MCADD. At the present time, we are not certain how many patients exist in this category."

In addition to Drs. Venditti and Stanley, other co-authors were Laura Venditti, M.Sc., and Henry Glick, Ph.D., both health economists from the University of Pennsylvania School of Medicine; and Gerard Berry, M.D., Paige Kaplan, M.D., and Edward Kaye, M.D., of the Division of Human Genetics and Molecular Biology at The Children’s Hospital of Philadelphia.

John Ascenzi | EurekAlert!
Further information:
http://www.chop.edu.

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>